|
Hemoglobin A1c
(HbA1c, or glycosylated hemoglobin) provides a more reliable
indication of blood glucose control than individual blood glucose
readings, because it reflects overall blood glucose levels
during the preceding 60-90 days, and is not subject to the rapid
fluctuation
of individual blood glucose readings.
The American Diabetes Association recommends
HbA1c as the best way to assess blood glucose control. The
ADA recommends this test every 3 months for patients taking
insulin, and every 6 months for stable patients using oral
medication to control diabetes. According to ADA guidelines,
7% is the upper limit of normal, and action should be taken
if HbA1c is over 8%.
LifeLink Monitoring offers HbA1c
telemonitoring with a CLIA-approved test that requires
only a single drop of blood.
|
